BI 764532

BI 764532 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BI 764532, covering 2025-10-28 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer [Phase 1]

See pricing